Mar 26, 2026 / 12:00PM GMT
Presentation
Mar 26, 2026 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Yuly Chen
Ascentage Pharma Group International - Senior Director of Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Zhichao Si
Ascentage Pharma Group International - Head of Commercial
=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Sandler - Analyst
* Supawat Thongthip
Truist Securities - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Matthew Biegler
Oppenheimer & Co Inc - Analyst
* Christopher Liu
Lucid Capital Markets LLC - Analyst
* Michael King
Rodman & Renshaw - Analyst
=====================
Operator
Ascentage Pharma Group International
(STU:36X)
€
3.96
-0.080 (-1.98%)
Market Cap: 1.54 Bil
Enterprise Value: 1.48 Bil
PE Ratio: 0
PB Ratio: 9.92
GF Score: 78/100 Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript
Mar 26, 2026 / 12:00PM GMT
Release Date Price:
€4.62
(-3.35%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot